Merck KGaA CFO Says More Deals Likely Amid Covid Boom

The transcript discusses the impact of COVID-19 on the life sciences sector, highlighting assumptions about the pandemic's progression and its effects on business demand. It addresses supply chain challenges, particularly in single-use products and filtration, and outlines investments to mitigate these issues. The conversation also covers the potential for COVID-19 to become endemic, influencing ongoing demand for vaccines and testing. Business growth strategies, including acquisitions and financial planning, are explored, with a focus on organic growth in life sciences and semiconductors. The semiconductor supply crunch is examined, emphasizing the need for strategic positioning to capitalize on growth opportunities.

What are the organic growth opportunities mentioned due to the COVID-19 pandemic?

How is the semiconductor supply crunch affecting the business?

What strategies are being considered for future acquisitions?